Skip to content

Author

Fed Ghali

We have 2 of 9 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

53 Nephrectomy Remodels Peripheral Myeloid Cell States in Renal Cell Carcinoma

Abstract Background Renal cell carcinoma (RCC) is a highly immunogenic cancer characterized by abundant CD8+ T cell infiltration, yet most patients do not achieve durable responses to immunotherapy. Notably, surgical removal of the primary tumor, even in metastatic disease, may enhance response to immunotherapy, an eff...

S. Schwartz, L. Wirth, Julia Walker et al. · 0 citations
Open access Sep 2026

14 Evaluation of the Effects of the HIF-2α Inhibitor Belzutifan on T-cell–Mediated Cytotoxicity in Renal Cell Carcinoma

An in vitro RCC antigen model system was established to evaluate the impact of belzutifan on T-cell cytotoxicity and revealed that IL-2 and IFNG were among the most significantly downregulated genes in HIF2α knockout T cells.

S. Kashima, Katrine N. Madsen, H. Soulati et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.